Authors
Loading...
Randomized trial investigates BCL6's role in type 1 diabetes pathogenesis, highlighting novel therapeutic targets.
McNitt et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: